{
    "organizations": [],
    "uuid": "5bb7195118bb7dcc215bd6923a988f22307e3ec2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ucb-files-for-acceptance-with-chin/brief-ucb-files-for-acceptance-with-china-food-and-drug-administration-for-cimzia-idUSFWN1RB0ZN",
    "ord_in_thread": 0,
    "title": "BRIEF-UCB Files For Acceptance With China Food And Drug Administration For Cimzia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 30 (Reuters) - UCB SA:\n* UCB ANNOUNCES FILING ACCEPTANCE WITH CHINA FOOD AND DRUG ADMINISTRATION FOR CIMZIA FOR TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS\n* CIMZIA IS NOT CURRENTLY MARKETED IN CHINA Source text: bit.ly/2uzs45O Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-30T13:08:00.000+03:00",
    "crawled": "2018-03-31T19:19:11.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "ucb",
        "sa",
        "ucb",
        "announces",
        "filing",
        "acceptance",
        "china",
        "food",
        "drug",
        "administration",
        "cimzia",
        "treatment",
        "rheumatoid",
        "arthritis",
        "cimzia",
        "currently",
        "marketed",
        "china",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}